Cargando…
Stability of the Transthyretin Molecule as a Key Factor in the Interaction with A-Beta Peptide - Relevance in Alzheimer's Disease
Transthyretin (TTR) protects against A-Beta toxicity by binding the peptide thus inhibiting its aggregation. Previous work showed different TTR mutations interact differently with A-Beta, with increasing affinities correlating with decreasing amyloidogenecity of the TTR mutant; this did not impact o...
Autores principales: | Ribeiro, Carlos A., Saraiva, Maria João, Cardoso, Isabel |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3444465/ https://www.ncbi.nlm.nih.gov/pubmed/23028965 http://dx.doi.org/10.1371/journal.pone.0045368 |
Ejemplares similares
-
Transthyretin Protects against A-Beta Peptide Toxicity by Proteolytic Cleavage of the Peptide: A Mechanism Sensitive to the Kunitz Protease Inhibitor
por: Costa, Rita, et al.
Publicado: (2008) -
Transthyretin participates in beta-amyloid transport from the brain to the liver- involvement of the low-density lipoprotein receptor-related protein 1?
por: Alemi, Mobina, et al.
Publicado: (2016) -
Calorimetric Studies
of Binary and Ternary Molecular
Interactions between Transthyretin, Aβ Peptides, and Small-Molecule
Chaperones toward an Alternative Strategy for Alzheimer’s Disease
Drug Discovery
por: Cotrina, Ellen Y., et al.
Publicado: (2020) -
Synergy of combined Doxycycline/TUDCA treatment in lowering Transthyretin deposition and associated biomarkers: studies in FAP mouse models
por: Cardoso, Isabel, et al.
Publicado: (2010) -
Correction: Transthyretin expression in the postischemic brain
por: Talhada, Daniela, et al.
Publicado: (2020)